hVIVO plc

Research hVIVO plc (HVO) on Bullrun: market cap GBX 4.99B, dividend yield 2.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHVO
• ExchangeLSE
• CountryUnited Kingdom
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyGBX
• Market capGBX 4.99B
• Dividend yield2.7%
• Financial periodFY2025
• RevenueGBP 46.77M
• Revenue growth-25.4%
• Net income-GBP 5.99M
• Free cash flow-GBP 15.85M

Valuation Snapshot

latest market cap is GBX 4.99B; dividend yield is 2.7%.

About hVIVO plc

hVIVO plc operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America. It provides end-to-end early clinical development services to the biopharmaceutical industry, including phase I capabilities and world leading human challenge trial services. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials;

Frequently asked questions

What is hVIVO plc's market cap?

hVIVO plc's market capitalization is GBX 4.99B.

Does hVIVO plc pay a dividend?

hVIVO plc has a dividend yield of 2.7%.

What does hVIVO plc do?

hVIVO plc operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.